40 related articles for article (PubMed ID: 38737036)
1. Anticancer therapeutic strategies for targeting mutant p53-Y220C.
Chasov V; Davletshin D; Gilyazova E; Mirgayazova R; Kudriaeva A; Khadiullina R; Yuan Y; Bulatov E
J Biomed Res; 2024 May; 38(3):222-232. PubMed ID: 38738269
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators.
Balourdas DI; Markl AM; Krämer A; Settanni G; Joerger AC
Cell Death Dis; 2024 Jun; 15(6):408. PubMed ID: 38862470
[TBL] [Abstract][Full Text] [Related]
3. Reconnaissance of Allostery via the Restoration of Native p53 DNA-Binding Domain Dynamics in Y220C Mutant p53 Tumor Suppressor Protein.
Han ISM; Thayer KM
ACS Omega; 2024 May; 9(18):19837-19847. PubMed ID: 38737036
[TBL] [Abstract][Full Text] [Related]
4. Mutagenic Activation of Glutathione Peroxidase-4: Approaches toward Rational Design of Allosteric Drugs.
Ma C; Chung DJ; Abramson D; Langley DR; Thayer KM
ACS Omega; 2022 Aug; 7(34):29587-29597. PubMed ID: 36061715
[TBL] [Abstract][Full Text] [Related]
5. Insights into Rational Design of a New Class of Allosteric Effectors with Molecular Dynamics Markov State Models and Network Theory.
Han ISM; Abramson D; Thayer KM
ACS Omega; 2022 Jan; 7(3):2831-2841. PubMed ID: 35097279
[TBL] [Abstract][Full Text] [Related]
6. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings.
Eberhardt J; Santos-Martins D; Tillack AF; Forli S
J Chem Inf Model; 2021 Aug; 61(8):3891-3898. PubMed ID: 34278794
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the Heuristic Nature of
Bremer PL; De Boer D; Alvarado W; Martinez X; Sorin EJ
J Chem Inf Model; 2020 Jun; 60(6):3081-3092. PubMed ID: 32383869
[TBL] [Abstract][Full Text] [Related]
8. Spectral analysis of molecular dynamics simulations on PDZ: MD sectors.
Lakhani B; Thayer KM; Black E; Beveridge DL
J Biomol Struct Dyn; 2020 Feb; 38(3):781-790. PubMed ID: 31262238
[TBL] [Abstract][Full Text] [Related]
9. Salvation of the fallen angel: Reactivating mutant p53.
Li Y; Wang Z; Chen Y; Petersen RB; Zheng L; Huang K
Br J Pharmacol; 2019 Apr; 176(7):817-831. PubMed ID: 30632144
[TBL] [Abstract][Full Text] [Related]
10. Dissecting Structure-Encoded Determinants of Allosteric Cross-Talk between Post-Translational Modification Sites in the Hsp90 Chaperones.
Stetz G; Tse A; Verkhivker GM
Sci Rep; 2018 May; 8(1):6899. PubMed ID: 29720613
[TBL] [Abstract][Full Text] [Related]
11. Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines.
Baud MGJ; Bauer MR; Verduci L; Dingler FA; Patel KJ; Horil Roy D; Joerger AC; Fersht AR
Eur J Med Chem; 2018 May; 152():101-114. PubMed ID: 29702446
[TBL] [Abstract][Full Text] [Related]
12. Molecular Dynamics-Markov State Model of Protein Ligand Binding and Allostery in CRIB-PDZ: Conformational Selection and Induced Fit.
Thayer KM; Lakhani B; Beveridge DL
J Phys Chem B; 2017 Jun; 121(22):5509-5514. PubMed ID: 28489401
[TBL] [Abstract][Full Text] [Related]
13. 2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells.
Bauer MR; Joerger AC; Fersht AR
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):E5271-80. PubMed ID: 27551077
[TBL] [Abstract][Full Text] [Related]
14. Structural Basis for p53 Lys120-Acetylation-Dependent DNA-Binding Mode.
Vainer R; Cohen S; Shahar A; Zarivach R; Arbely E
J Mol Biol; 2016 Jul; 428(15):3013-25. PubMed ID: 27338200
[TBL] [Abstract][Full Text] [Related]
15. Evolution-Based Functional Decomposition of Proteins.
Rivoire O; Reynolds KA; Ranganathan R
PLoS Comput Biol; 2016 Jun; 12(6):e1004817. PubMed ID: 27254668
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Statistical Mechanical Model Accounts for the Causality and Energetics of Allosteric Communication.
Guarnera E; Berezovsky IN
PLoS Comput Biol; 2016 Mar; 12(3):e1004678. PubMed ID: 26939022
[TBL] [Abstract][Full Text] [Related]
17. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.
Maier JA; Martinez C; Kasavajhala K; Wickstrom L; Hauser KE; Simmerling C
J Chem Theory Comput; 2015 Aug; 11(8):3696-713. PubMed ID: 26574453
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Transmission of Protein Allostery without Structural Change: Spatial Pathways or Global Modes?
McLeish TC; Cann MJ; Rodgers TL
Biophys J; 2015 Sep; 109(6):1240-50. PubMed ID: 26338443
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
